TRIAL OF HIGH-DOSE EDMONSTON-ZAGREB MEASLES VACCINE IN THE GAMBIA: ANTIBODY RESPONSE AND SIDE-EFFECTS
- 1 October 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 332 (8615) , 811-814
- https://doi.org/10.1016/s0140-6736(88)92781-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- EFFECTS OF DOSE AND STRAIN OF VACCINE ON SUCCESS OF MEASLES VACCINATION OF INFANTS AGED 4-5 MONTHSThe Lancet, 1988
- Further Community Studies on the Role of Overcrowding and Intensive Exposure on Measles MortalityClinical Infectious Diseases, 1988
- COMPARISON OF EDMONSTON-ZAGREB AND SCHWARZ STRAINS OF MEASLES VACCINE GIVEN BY AEROSOL OR SUBCUTANEOUS INJECTIONThe Lancet, 1987
- MEASLES CONTROL IN YAOUNDE: JUSTIFICATION OF A ONE DOSE, NINE MONTH MINIMUM AGE VACCINATION POLICY IN TROPICAL AFRICAThe Lancet, 1983
- AGE-SPECIFIC OCCURRENCE RATES OF MEASLES IN URBAN, PERI-URBAN, AND RURAL ENVIRONMENTS: IMPLICATIONS FOR TIME OF VACCINATIONThe Lancet, 1983
- Successful Immunization of Children With and Without Maternal Antibody by Aerosolized Measles VaccinePublished by American Medical Association (AMA) ,1983
- Status of Measles in The Gambia, 1981Clinical Infectious Diseases, 1983
- MEASLES MORTALITY AND VACCINE EFFICACY IN RURAL WEST AFRICAThe Lancet, 1983
- Measles in Children under Six Months of Age: An Epidemiological StudyJournal of Tropical Pediatrics, 1981